The French Cochlear Implant Registry (EPIIC): General indicators.


Journal

European annals of otorhinolaryngology, head and neck diseases
ISSN: 1879-730X
Titre abrégé: Eur Ann Otorhinolaryngol Head Neck Dis
Pays: France
ID NLM: 101531465

Informations de publication

Date de publication:
Sep 2020
Historique:
pubmed: 7 9 2020
medline: 9 9 2021
entrez: 6 9 2020
Statut: ppublish

Résumé

Cochlear and brainstem implants have been included on the list of reimbursable products (LPPR) in France since March of 2009. The implants were initially inscribed for 5 years, after which an application for renewal with the French National Commission for the Evaluation of Medical Devices and Health Technologies (Commission Nationale d'évaluation des dispositifs médicaux et des technologies de santé - CNEDiMTS) was required [Haute Autorité de santé, 2009]. Upon registration to the list of reimbursable products, the companies and the reference centers for cochlear and brainstem implants were asked to set up a post-registration registry called EPIIC. This article reports the evolution in the EPIIC registry of the general indicators for 5051 patients over the five years from 2012-2016.

Identifiants

pubmed: 32891589
pii: S1879-7296(20)30175-7
doi: 10.1016/j.anorl.2020.07.009
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

S5-S9

Informations de copyright

Copyright © 2020. Published by Elsevier Masson SAS.

Auteurs

F Gauvrit (F)

Service d'Otologie et d'Otoneurologie, CHU de Lille, rue Emile-Laine, 59037 Lille, France.

M Risoud (M)

Service d'Otologie et d'Otoneurologie, CHU de Lille, rue Emile-Laine, 59037 Lille, France.

K Aubry (K)

CHU de Limoges, Limoges, France.

P Bordure (P)

CHU de Nantes, Nantes, France.

A Bozorg-Grayeli (A)

CHU de Dijon, Dijon, France.

O Deguine (O)

CHU de Toulouse, Toulouse, France.

C Eyermann (C)

CHU de Strasbourg, Strasbourg, France.

V Franco-Vidal (V)

CHU de Bordeaux, Bordeaux, France.

B Godey (B)

CHU de Rennes, Rennes, France.

N Guevara (N)

CHU de Nice, Nice, France.

A Karkas (A)

CHU de St Etienne, Saint-Etienne, France.

N Klopp (N)

CHU d'Amiens, Amiens, France.

M Labrousse (M)

CHU de Reims, Reims, France.

J-P Lebreton (JP)

CHU de Poitiers, Poitiers, France.

Y Lerosey (Y)

CHU de Rouen, Rouen, France.

E Lescanne (E)

CHU de Tours, Tours, France.

N Loundon (N)

Hôpital Necker, Paris, France.

R Marianowski (R)

CHU de Brest, Brest, France.

F Merklen (F)

CHU de Montpellier, Montpellier, France.

K Mezouaghi (K)

CH de La Réunion, La Réunion, France.

T Mom (T)

CHU de Clermont-Ferrand, Clermont-Ferrand, France.

S Moreau (S)

CHU de Caen, Caen, France.

I Mosnier (I)

Hôpital Pitié-Salpétrière, Paris, France.

N Noël-Petroff (N)

Hôpital Robert-Debré, Paris, France.

C Parietti (C)

CHU de Nancy, Nancy, France.

P Piller (P)

CHT de Nouméa - Nouvelle-Calédonie, France.

C Poncet (C)

Hôpital Rothschild, Paris, France.

E Radafy (E)

CH du Lamentin, Martinique, France.

S Roman (S)

CHU de Marseille, Marseille, France.

S Roux-Vaillard (S)

CHU d'Angers, Angers, France.

S Schmerber (S)

CHU de Grenoble, La Tronche, France.

L Tavernier (L)

CHU de Besançon, Besançon, France.

E Truy (E)

CHU de Lyon, Lyon, France.

C Vincent (C)

Service d'Otologie et d'Otoneurologie, CHU de Lille, rue Emile-Laine, 59037 Lille, France. Electronic address: otologie@chru-lille.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH